M Schneider, M Koch - Neuropsychopharmacology, 2003 - nature.com
There is evidence from studies in humans and animals that a vulnerable period for chronic cannabinoid administration exists during certain phases of development. The present study …
Since the aetiology and the neuropathology of schizophrenia still largely eludes us, the development of animal models for this severe psychiatric disease has remained a difficult …
H Swadi, C Bobier - Australian & New Zealand Journal of …, 2003 - journals.sagepub.com
Objective: Substance abuse/dependence has been reported to show significant association with psychopathology, and is likely to influence the course and outcome of psychiatric …
BA Ellenbroek - Behavioural pharmacology, 2003 - journals.lww.com
Although the advances in molecular genetics have revolutionized many areas of the life sciences, they have, so far, been of limited use in the development of animal models for …
Understanding the etiology of schizophrenia has been a considerable challenge. The neurodevelopmental hypothesis has held sway in recent years, focusing our attention on …
There is currently a debate about the appropriate approach to prevention of schizophrenia. While many argue that prevention efforts should focus on individuals at high risk of …
EM Tsapakis, O Guillin, RM Murray - Current Opinion in Psychiatry, 2003 - journals.lww.com
Drugs that release dopamine, such as amphetamines and cocaine, have long been known to be associated with schizophrenia. As Professor Stefanis pointed out many years ago …
J Royo-Isach, M Magrané, A Velilla, R Martí - Atención primaria, 2003 - core.ac.uk
etc.), por lo que sus efectos pueden presentar variaciones, alteraciones y hasta intoxicaciones en función del estado y las mezclas de los productos utilizados.–El …
K Soares-Weiser, M Weiser… - Brazilian Journal of …, 2003 - SciELO Brasil
Editorial bém longitudinal, foi realizado numa população de 4.045 adolescentes e demonstrou um aumento de quase três vezes no risco de sintomas psicóticos em …